Human Endogenous Retroviruses (HERVs) and Mammalian Apparent LTRs Retrotransposons (MaLRs) Are Dynamically Modulated in Different Stages of Immunity

• Published in: Biology (Basel, Switzerland) Vol. 10; no. 5; p. 405
• Main Authors: Pisano, Maria Paola, Grandi, Nicole, Tramontano, Enzo
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 05.05.2021; MDPI
• Subjects: adults; Bioinformatics; Datasets; Developmental stages; differential expression; etiological agents; fever; Gene expression; gene expression regulation; Genomes; Hantaan orthohantavirus; Hemorrhage; HERV; humans; Immune response; immunity; inactivated vaccines; Korean hemorrhagic fever; MaLR; Multiple sclerosis; Principal components analysis; retrotransposons; Retroviridae; RNA-seq; sequence analysis; Software; Transcription; transcription (genetics); transcriptome; Transcriptomes; vaccine; Vaccines
• ISSN: 2079-7737; 2079-7737
• DOI: 10.3390/biology10050405

Human Endogenous retroviruses (HERVs) and Mammalian Apparent LTRs Retrotransposons (MaLRs) are remnants of ancient retroviral infections that represent a large fraction of our genome. The HERV and MaLR transcriptional activity is regulated in developmental stages, adult tissues, and pathological conditions. In this work, we used a bioinformatics approach based on RNA-sequencing (RNA-seq) to study the expression and modulation of HERVs and MaLR in a scenario of activation of the immune response. We analyzed transcriptome data from subjects before and after the administration of an inactivated vaccine against the Hantaan orthohantavirus, the causative agent of Korean hemorrhagic fever, to investigate the HERV and MaLR expression and differential expression in response to the administration of the vaccine. Specifically, we described the HERV transcriptome in PBMCs and identified HERV and MaLR loci differentially expressed after the 2nd, 3rd, and 4th inactivated vaccine administrations. We found that the expression of 545 HERV and MaLR elements increased in response to the vaccine and that the activation of several individual HERV and MaLR loci is specific for each vaccine administration and correlated to different genes and immune-related pathways.